Biomarkers in Neuropsychiatry最新文献

筛选
英文 中文
Inter-device reliability of swept source and spectral domain optical coherence tomography and retinal layer differences in schizophrenia 扫描源和光谱域光学相干断层扫描的设备间可靠性与精神分裂症的视网膜层差异
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100036
Swetha Gandu , Deepthi Bannai , Iniya Adhan , Megan Kasetty , Raviv Katz , Rebecca Zang , Olivia Lutz , Leo A. Kim , Matcheri Keshavan , John B. Miller , Paulo Lizano
{"title":"Inter-device reliability of swept source and spectral domain optical coherence tomography and retinal layer differences in schizophrenia","authors":"Swetha Gandu ,&nbsp;Deepthi Bannai ,&nbsp;Iniya Adhan ,&nbsp;Megan Kasetty ,&nbsp;Raviv Katz ,&nbsp;Rebecca Zang ,&nbsp;Olivia Lutz ,&nbsp;Leo A. Kim ,&nbsp;Matcheri Keshavan ,&nbsp;John B. Miller ,&nbsp;Paulo Lizano","doi":"10.1016/j.bionps.2021.100036","DOIUrl":"10.1016/j.bionps.2021.100036","url":null,"abstract":"<div><h3>Introduction</h3><p>Optical coherence tomography (OCT) is used to study retinal structure in schizophrenia. Changes in retinal structure, especially the retinal nerve fiber layer (RNFL) has been correlated with psychotic disorders. Measurement variability is a concern since there are various generations of OCT devices. We investigated the inter- and intra-device agreement of macular thickness between spectral domain (SD−OCT) and swept source−OCT (SS−OCT), and compared macula and peripapillary group differences in schizophrenia using SS−OCT.</p></div><div><h3>Methods</h3><p>Macular OCT thickness was obtained for schizophrenia (SZ, n = 30) and healthy controls (HC, n = 22) subjects using SD−OCT (Heidelberg Spectralis) and SS−OCT (DRI Topcon Triton). Peripapillary thickness was obtained using SS−OCT. RNFL, ganglion cell-inner plexiform complex (GCL+), RNFL plus GCL+ (GCL++), and macular thickness were collected. Clinical and cognitive data were gathered. All statistical analyses were performed using R software.</p></div><div><h3>Results</h3><p>There was excellent inter-scanner agreement for GCL + and GCL++ with ICC’s between r = 0.92−0.99. Good-to-excellent intra-scanner (OD vs OS) agreement was present except for macular RNFL in the SS−OCT device. No significant peripapillary group differences were identified. Poorer GAF scores were correlated with thinner macular layers and thinner overall peripapillary retinal layer. Greater mania symptoms were associated with smaller peripapillary GCL + thickness (r=-0.43, p = 0.03). Poor overall cognition (Brief Assessment of Cognition in Schizophrenia) was associated with smaller overall peripapillary retinal thickness (r = 0.36, p = 0.02).</p></div><div><h3>Conclusion</h3><p>While there is RNFL variability, GCL + and GCL++ are comparable between scanners SD−OCT and SS−OCT. Given that RNFL thinning is strongly implicated in psychotic disorders, the use of OCT scanners should not be interchanged due to increased RNFL measurement variability.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionps.2021.100036","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"94779757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis 首发精神病患者抗精神病药物、氨基酸特征和血小板活化因子的特征
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100045
Bracha Erlanger Avigdor , Kun Yang , Ida Shinder , Benjamin C. Orsburn , Rana Rais , Shin-ichi Kano , Akira Sawa , Jonathan Pevsner
{"title":"Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis","authors":"Bracha Erlanger Avigdor ,&nbsp;Kun Yang ,&nbsp;Ida Shinder ,&nbsp;Benjamin C. Orsburn ,&nbsp;Rana Rais ,&nbsp;Shin-ichi Kano ,&nbsp;Akira Sawa ,&nbsp;Jonathan Pevsner","doi":"10.1016/j.bionps.2021.100045","DOIUrl":"10.1016/j.bionps.2021.100045","url":null,"abstract":"<div><p>First-episode psychosis refers to individuals early in the course of psychotic illness. Identifying the underlying biological processes, including biomarkers, is essential for improving diagnosis and treatment. We performed metabolomics profiling of plasma from a group of first-episode psychosis patients and matched neurotypical controls. Using global metabolomics profiling, we identified antipsychotic or antidepressant medication in 22 individuals diagnosed with first-episode psychosis, closely matching the drug prescription history. There were significant differences in levels of amino acids or their derivatives, including decreases in D<span>L</span>-arginine, <span>L</span>-histidine, DL-serine and threonine as well as increases in <span>L</span>-glutamic acid, ornithine, and proline. Using targeted metabolomics profiling of 408 compounds in plasma samples we identified significant differences in six compounds including decreases in serotonin and arginine as well as increased levels of sarcosine, proline, cis-4-hydroxyproline and trans-4-hydroxyproline. Platelet-activating factor levels were significantly elevated in the FEP cohort. These findings suggest potential biomarkers that require validation in independent cohorts, and in several cases provide supporting evidence for previously reported observations.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666144621000162/pdfft?md5=81c9985e9e4c46bb8f2a0ebd904acbb9&pid=1-s2.0-S2666144621000162-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46531561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Anterior-posterior axis of hippocampal subfields across psychoses: A B-SNIP study 精神病患者海马亚区前后轴:一项B-SNIP研究
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100037
Elisabetta C. del Re , Victor Zeng , Ney Alliey-Rodriguez , Paulo Lizano , Nicolas Bolo , Olivia Lutz , Godfrey Pearlson , John A. Sweeney , Brett A. Clementz , Elliot Gershon , Carol A. Tamminga , Matcheri S. Keshavan
{"title":"Anterior-posterior axis of hippocampal subfields across psychoses: A B-SNIP study","authors":"Elisabetta C. del Re ,&nbsp;Victor Zeng ,&nbsp;Ney Alliey-Rodriguez ,&nbsp;Paulo Lizano ,&nbsp;Nicolas Bolo ,&nbsp;Olivia Lutz ,&nbsp;Godfrey Pearlson ,&nbsp;John A. Sweeney ,&nbsp;Brett A. Clementz ,&nbsp;Elliot Gershon ,&nbsp;Carol A. Tamminga ,&nbsp;Matcheri S. Keshavan","doi":"10.1016/j.bionps.2021.100037","DOIUrl":"10.1016/j.bionps.2021.100037","url":null,"abstract":"<div><h3>Background</h3><p>The hippocampus (HP) is affected across psychoses, including schizophrenia (SZ), bipolar type 1 (BDP) and schizoaffective (SAD) disorders. We examined HP subfield volumetric abnormalities along the anterior-posterior (ventral-dorsal) axis of the HP in psychosis probands, defined by traditional (DSM) diagnoses and biologically defined subtypes (biotypes, based on cognition and electrophysiology). We hypothesized that biotypes would be better discriminated by HP longitudinal axis subfields abnormalities than DSM.</p></div><div><h3>Methods</h3><p>The sample included 455 probands from the Bipolar Schizophrenia Network for intermediate Phenotypes (BSNIP) dataset (age 35<!--> <!-->±<!--> <!-->12.0): 124 unaffected (age 40.4<!--> <!-->±<!--> <!-->15.8) and 299 healthy controls (HC; 37<!--> <!-->±<!--> <!-->12.0). Probands were: SZ (190), BDP (151), SAD (114). Probands according to B-SNIP defined biotypes were: biotype-1 (BT1; 120), biotype-2 (BT2; 145), biotype-3 (BT3, 190). 3<!--> <!-->T MRI scans were processed with FreeSurfer6.0. The anterior (aHP) and posterior (pHP) HP and aHP and pHP subfields were extracted. Cognitive and clinical data were collected.</p></div><div><h3>Results</h3><p>All biotypes had smaller aHP subfields compared to HC. BT1 had smaller aHP than both BT2 and BT3. pHP subfields were also smaller in BT1 compared to HC and BT3, while the granule cells layer of the dentate gyrus distinguished BT2 from HC. DSM: aHP subfields were smaller in all DSM types compared to HC and did not differ among DSM categories. A few pHP subfields were affected in SAD and SZ compared to HC and distinguished SAD and SZ from BDP. Probands had smaller aHP compared to unaffected relatives.</p></div><div><h3>Conclusions</h3><p>Differences in subfield volumetric abnormalities along the anterior- posterior axis of the HP exist across psychoses. aHP abnormalities differ between psychosis probands and HC but do not discriminate among DSM categories. In contrast, biotypes can be differentiated from HC and from each other according to aHP-pHP subfields volumetric abnormalities. Thus, biotype typology may better reflect underlying neurobiology.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionps.2021.100037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"94848968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Gene expression of methylation cycle and related genes in lymphocytes and brain of patients with schizophrenia and non-psychotic controls 精神分裂症患者和非精神病性对照组淋巴细胞和大脑甲基化周期及相关基因的基因表达
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100038
Henry Sershen , Alessandro Guidotti , James Auta , Jenny Drnevich , Dennis R. Grayson , Marin Veldic , Jordan Meyers , Mary Youseff , Adrian Zhubi , Keturah Faurot , Renrong Wu , Jingping Zhao , Hua Jin , Abel Lajtha , John M. Davis , Robert C. Smith
{"title":"Gene expression of methylation cycle and related genes in lymphocytes and brain of patients with schizophrenia and non-psychotic controls","authors":"Henry Sershen ,&nbsp;Alessandro Guidotti ,&nbsp;James Auta ,&nbsp;Jenny Drnevich ,&nbsp;Dennis R. Grayson ,&nbsp;Marin Veldic ,&nbsp;Jordan Meyers ,&nbsp;Mary Youseff ,&nbsp;Adrian Zhubi ,&nbsp;Keturah Faurot ,&nbsp;Renrong Wu ,&nbsp;Jingping Zhao ,&nbsp;Hua Jin ,&nbsp;Abel Lajtha ,&nbsp;John M. Davis ,&nbsp;Robert C. Smith","doi":"10.1016/j.bionps.2021.100038","DOIUrl":"10.1016/j.bionps.2021.100038","url":null,"abstract":"<div><p>Some of the biochemical abnormalities underlying schizophrenia, involve differences in methylation and methylating enzymes, as well as other related target genes. We present results of a study of differences in mRNA expression in peripheral blood lymphocytes (PBLs) and post-mortem brains of chronic schizophrenics (CSZ) and non-psychotic controls (NPC), emphasizing the differential effects of sex and antipsychotic drug treatment on mRNA findings. We studied mRNA expression in lymphocytes of 61 CSZ and 49 NPC subjects using qPCR assays with TaqMan probes to assess levels of DNMT, TET, GABAergic, NR3C1, BDNF mRNAs, and several additional targets identified in a recent RNA sequence analysis. In parallel we studied DNMT1 and GAD67 in samples of brain tissues from 19 CSZ, 26 NPC. In PBLs DNMT1 and DNMT3A mRNA levels were significantly higher in male CSZ vs NPC No significant differences were detected in females. The GAD1, NR3C1 and CNTNAP2 mRNA levels were significantly higher in CSZ than NPC. In CSZ patients treated with clozapine, GAD-1 related, CNTNAP2, and IMPA2 mRNAs were significantly higher than in CSZ subjects not treated with clozapine. Differences between CSZ vs NPC in these mRNAs was primarily attributable to the clozapine treatment. In the brain samples, DNMT1 was significantly higher and GAD67 was significantly lower in CSZ than in NPC, but there were no significant sex differences in diagnostic effects. These findings highlight the importance of considering sex and drug treatment effects in assessing the substantive significance of differences in mRNAs between CSZ and NPC.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionps.2021.100038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39292686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Reduced pituitary volume with relative T1 shortening correlates with behavior in Prader-Willi syndrome 垂体体积减小与T1相对缩短与Prader-Willi综合征的行为相关
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100039
Kenichi Yamada , Masaki Watanabe, Kiyotaka Suzuki
{"title":"Reduced pituitary volume with relative T1 shortening correlates with behavior in Prader-Willi syndrome","authors":"Kenichi Yamada ,&nbsp;Masaki Watanabe,&nbsp;Kiyotaka Suzuki","doi":"10.1016/j.bionps.2021.100039","DOIUrl":"10.1016/j.bionps.2021.100039","url":null,"abstract":"<div><p>Prader-Willi syndrome is a complex endocrinological and developmental disorder characterized by hyperphagic, autistic, and obsessive behaviors, which have been considered to primarily originate from hypothalamus-pituitary axis system alterations in the brain. While the pituitary gland has been demonstrated to contribute to behavioral phenotypes associated with neuropeptide, e.g., arginine-vasopressin, the relevant alterations in Prader-Willi syndrome remain unknown. This study aimed to investigate developmental abnormalities in the pituitary gland structures and determine whether the structural abnormalities are associated with behavioral characteristics in Prader-Willi syndrome. In total, 21 Japanese individuals with Prader-Willi syndrome and 31 healthy controls with typical development were included. Compared with the control group, the Prader-Willi syndrome group showed reduced anterior and posterior pituitary volume ratios per total intracranial volume with relative T<sub>1</sub> shortening in an age-associated manner. Moreover, altered volume ratios and signal intensities were negatively correlated with hyperphagia and autistic questionnaire scores but positively correlated with obsessive scores. The findings suggest that structural and functional alterations, in part due to altered hypothalamus-pituitary function, may contribute to the behavior in Prader-Willi syndrome. The imaging-behavior correlates and in vivo neurochemical visualization of the pituitary gland might be potential intrinsic biomarkers for behavioral phenotypes in Prader-Willi syndrome and other neurodevelopmental disorders.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionps.2021.100039","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"97116985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A pilot spectroscopy study of adversity in adolescents 青少年逆境的初步光谱研究
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100043
A. Irem Sonmez , Charles P. Lewis , John D. Port , Arjun P. Athreya , Doo-Sop Choi , Michael J. Zaccariello , Julia Shekunov , Caren J. Blacker , Paul E. Croarkin
{"title":"A pilot spectroscopy study of adversity in adolescents","authors":"A. Irem Sonmez ,&nbsp;Charles P. Lewis ,&nbsp;John D. Port ,&nbsp;Arjun P. Athreya ,&nbsp;Doo-Sop Choi ,&nbsp;Michael J. Zaccariello ,&nbsp;Julia Shekunov ,&nbsp;Caren J. Blacker ,&nbsp;Paul E. Croarkin","doi":"10.1016/j.bionps.2021.100043","DOIUrl":"10.1016/j.bionps.2021.100043","url":null,"abstract":"<div><h3>Background</h3><p>Childhood adversity is a global health problem affecting 25–50% of children worldwide. Few prior studies have examined the underlying neurochemistry of adversity in adolescents. This cross-sectional study examined spectroscopic markers of trauma in a cohort of adolescents with major depressive disorder (MDD) and healthy controls. We hypothesized that historical adversity would have a negative relationship with spectroscopic measures of glutamate metabolites in anterior cingulate cortex.</p></div><div><h3>Methods</h3><p>Adolescent participants (aged 13–21) underwent a semi-structured diagnostic interview and clinical assessment, which included the self-report Childhood Trauma Questionnaire (CTQ), a 28-item assessment of childhood adversity. Proton magnetic resonance spectroscopy (<sup>1</sup>H-MRS) scans at 3 Tesla of an anterior cingulate cortex (ACC) voxel (8 cm<sup>3</sup>) encompassing both hemispheres were collected using a 2-dimensional <em>J</em>-averaged sequence to assess <em>N</em>-acetylaspartate (NAA), Glx (glutamate+glutamine) and [NAA]/[Glx] concentrations. Generalized linear models assessed the relationships between CTQ scores and metabolite levels in ACC.</p></div><div><h3>Results</h3><p>Thirty-nine participants (17 healthy controls, 22 depressed participants) underwent <sup>1</sup>H-MRS and completed the CTQ measures. There were decrements in [NAA]/[Glx] ratio in the ACC of participants with childhood adversity while no significant relationship between CTQ total score and any of the ACC metabolites was found in the combined sample. Exploratory results revealed a positive association between Glx levels and CTQ scores in depressed participants. Conversely the [NAA]/[Glx] ratio had a negative association with total CTQ scores in the depressed participants. Emotional Abuse Scale showed a significant negative relationship with [NAA]/[Glx] ratio in the combined sample when adjusted for depression severity.</p></div><div><h3>Conclusions</h3><p>Our findings suggest that childhood adversity may impact brain neurochemical profiles. Further longitudinal studies should examine neurochemical correlates of childhood adversity throughout development and in populations with other psychiatric disorders.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/82/nihms-1767100.PMC9248870.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40476509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior microrna在重度抑郁症和自杀行为中作为生物标志物的潜力
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100035
Gianluca Serafini , Alice Trabucco , Giovanni Corsini , Andrea Escelsior , Andrea Amerio , Andrea Aguglia , Henry Nasrallah , Mario Amore
{"title":"The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior","authors":"Gianluca Serafini ,&nbsp;Alice Trabucco ,&nbsp;Giovanni Corsini ,&nbsp;Andrea Escelsior ,&nbsp;Andrea Amerio ,&nbsp;Andrea Aguglia ,&nbsp;Henry Nasrallah ,&nbsp;Mario Amore","doi":"10.1016/j.bionps.2021.100035","DOIUrl":"10.1016/j.bionps.2021.100035","url":null,"abstract":"<div><p>Major affective disorder are common and disabling conditions linked to significant psychosocial impairment as well as negative outcome (e.g., suicidal behaviors) . According to a molecular perspective, major depressive disorder and suicidal behavior have been associated with structural and synaptic plasticity disturbances. Small non-coding RNAs, such as microRNAs (miRNAs), may play a significant role in the translational regulation of the synapse. This comprehensive overview is aimed to carefully review the preclinical and clinical literature results regarding the involvement of miRNAs in the pathophysiology and pharmacotherapy of major psychiatric conditions . MiRNAs may act as gene expression regulators critically affecting brain development. The alteration of some intracellular mechanisms together with impaired assembly, localization, and translational regulation of specific RNA binding proteins may affect important functions such as learning and memory contributing to the pathophysiology of major depressive disorder and suicidal behavior. Based on the main findings, most of the miRNAs which have been identified to date are expressed in human brain, where they regulate prominent neurobiological processes, such as neurogenesis and neuroplasticity. The main implications of the present findings are critically discussed.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionps.2021.100035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"110423453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Analysis of choroidal vessel density in patients with multiple sclerosis 多发性硬化患者脉络膜血管密度分析
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100040
Jeniffer Jesus , Raquel Soares , Rafael Geraldes , Maria Matias , João Chibante
{"title":"Analysis of choroidal vessel density in patients with multiple sclerosis","authors":"Jeniffer Jesus ,&nbsp;Raquel Soares ,&nbsp;Rafael Geraldes ,&nbsp;Maria Matias ,&nbsp;João Chibante","doi":"10.1016/j.bionps.2021.100040","DOIUrl":"10.1016/j.bionps.2021.100040","url":null,"abstract":"<div><h3>Introduction</h3><p>Multiple Sclerosis (MS) is a chronic neuro inflammatory disease which leads to progressive disability. Recent evidence suggests that vascular impairment may contribute to MS onset and progression. Optical Coherence Tomography Angiography (OCT-A) has emerged as an important imaging tool which should allow further exploration of the vessel changes in the pathogenesis and prognosis of MS.</p></div><div><h3>Purpose</h3><p>To quantify the vascular density (VD) of the choroid (CH) and choriocapillaris (CC) in patients with MS, comparing with normal eyes.</p></div><div><h3>Materials and Methods</h3><p>45 eyes of 45 MS patients [31 female; mean age (years ± SD) 41,87 ± 11.04; axial length (AL) (AL ± SD) 23.68 ± 0.90) and 45 aged-matched control subjects (33 female; mean age 39,.6 ± 8,93; AL 23.36 ± 0.75] were enrolled in this prospective study. We obtained OCT-A images based on a full-spectrum amplitude de-correlation angiography (FSADA) algorithm. The OCT-A images of the CH and CC were used for quantitative assessment in three regions of the fovea, namely, Region 1 (0–500 μm) Region 2 (500–1000 μm) and Region 3 (1000−1500 μm). Relationships of VD between MS patients with and without optic neuritis (ON) and controls were investigated by binary vessel maps generated from OCT-A slabs and analyzed using ImageJ software.</p></div><div><h3>Results</h3><p>Compared to controls, in eyes with MS, CH VD was significantly decreased in Region 2 (p = 0.01) and Region 3 (p &lt; 0.01). CCVD was not different between the groups although showing a decreasing tendency in the MS group. Between eyes with and without ON there were a tendency to reduced VD in the ON group in all regions analyzed for both CH and CC layer. All the layers analyzed revealed a positive correlation between CH VD and CC VD and a negative correlation between CC VD and AL.</p></div><div><h3>Conclusions</h3><p>Although studies have assessed retinal VD in MS using OCT-A, the choroidal vasculature in MS remains understudied. Our results cautiously suggest a functional circulatory disturbance of choroidal vasculatures in MS patients, mainly in those who have previous ON history.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionps.2021.100040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"93560341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Post-traumatic stress disorder: A biopsychosocial case-control study investigating peripheral blood protein biomarkers 创伤后应激障碍:一项调查外周血蛋白生物标志物的生物-心理-社会病例对照研究
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100042
Daniel Maguire , Joanne Watt , Cherie Armour , Melissa Milanak , Susan Lagdon , John V. Lamont , Mary Jo Kurth , Peter Fitzgerald , Tara Moore , Mark W. Ruddock
{"title":"Post-traumatic stress disorder: A biopsychosocial case-control study investigating peripheral blood protein biomarkers","authors":"Daniel Maguire ,&nbsp;Joanne Watt ,&nbsp;Cherie Armour ,&nbsp;Melissa Milanak ,&nbsp;Susan Lagdon ,&nbsp;John V. Lamont ,&nbsp;Mary Jo Kurth ,&nbsp;Peter Fitzgerald ,&nbsp;Tara Moore ,&nbsp;Mark W. Ruddock","doi":"10.1016/j.bionps.2021.100042","DOIUrl":"10.1016/j.bionps.2021.100042","url":null,"abstract":"<div><p>Experiencing traumatic events is unfortunately commonplace and, in some cases, may lead to the onset of debilitating mental health disorders, such as post-traumatic stress disorder (PTSD). Current diagnostic criteria for PTSD results in high depression and anxiety comorbidity. Better understanding of biological mechanisms and pathways underlying PTSD could aid in more accurate case identification and stratification of treatments. Recent meta-analysis has identified chronic PTSD to be associated with increased expression of pro-inflammatory cytokines and alterations in neuronal structures which contribute to an overall reduction in brain volume. Despite this, there are currently no biological markers in clinical use to identify PTSD or monitor treatment. This case-control study (n = 40) aimed to identify differences in peripheral blood biomarkers, and biomarker combinations, able to distinguish PTSD participants from controls, and examine in a biopsychosocial framework. The levels of 5/37 biomarkers investigated were significantly altered in the serum of PTSD participants: HDL and LDL cholesterol, tPA, IL-8 and EGF. Biomarkers could be used in combination with psychological criteria, in a biopsychosocial model, to support clinical management decisions and ensure appropriate individual treatment pathways.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666144621000137/pdfft?md5=73d2423b60848b106a92368a53ffdb8c&pid=1-s2.0-S2666144621000137-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42493362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosis 继发性进展性多发性硬化患者血清神经丝光浓度与肾功能无关
Biomarkers in Neuropsychiatry Pub Date : 2021-12-01 DOI: 10.1016/j.bionps.2021.100044
T. Williams , H. Zetterberg , J. Chataway
{"title":"Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosis","authors":"T. Williams ,&nbsp;H. Zetterberg ,&nbsp;J. Chataway","doi":"10.1016/j.bionps.2021.100044","DOIUrl":"10.1016/j.bionps.2021.100044","url":null,"abstract":"<div><h3>Background</h3><p>Neurofilament Light (NFL) is a promising biomarker of neuroaxonal injury. Its utility may be improved by expression relative to age-matched controls and by adjusting for other covariates, such as body mass index. It has recently been suggested that renal function may modulate the rate of clearance of NFL from circulation, which if confirmed would make renal function an important additional covariate to take into account when interpreting NFL data in research or clinical settings. Here we explore the relationship between renal function and NFL in a cohort of patients with secondary progressive multiple sclerosis (SPMS).</p></div><div><h3>Methods</h3><p>We examined data from patients with SPMS who took part in the MS-STAT randomised controlled trial. We use multivariable linear regression to explore the relationship between serum NFL and renal function, and additionally to examine whether including renal function as a covariate improves the ability of NFL to predict the subsequent rate of whole brain atrophy.</p></div><div><h3>Results</h3><p>Data on renal function and serum NFL was available for 122 patients. Mean eGFR 88 ml/min/1.73 m<sup>2</sup> (range 38.2–121.9). We found no evidence to support a relationship between renal function and serum NFL in this cohort. Furthermore, the inclusion of eGFR as a covariate in models assessing the relationship between NFL and the rate of whole brain atrophy had no significant effect upon the relationships observed.</p></div><div><h3>Conclusions</h3><p>We find no evidence for a relationship between renal function and NFL in a cohort of patients with secondary progressive multiple sclerosis. We hypothesise that the previously observed relationships between NFL and renal function related to associations between renal function and subclinical neuropathology, rather than due to modulating clearance of NFL from the circulation, but further research would be required to confirm such mechanisms.</p></div>","PeriodicalId":52767,"journal":{"name":"Biomarkers in Neuropsychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666144621000150/pdfft?md5=c6d9c9c04450fe116697648504114ae7&pid=1-s2.0-S2666144621000150-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48701122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信